Day: 2025-06-26

MAKKAH, SAUDI ARABIA, SA, June 26, 2025 - (ACN Newswire via SeaPRwire.com) - The General Authority for the Care of the Two Holy Mosques, represented by the King Abdulaziz Complex for the Holy Kaaba Kiswa, presided over the occasion of the replacing of the Kiswa on the first day of the month of Muharram (Hijri). This took place within an integrated operational system that reflects the Kingdom of Saudi Arabia's willingness and dedication to serving the Two Holy Mosques-continuing a legacy of over 100 years of care in producing the Kiswa for the Ancient House.Holy KaabaThe Ceremony of Changing the Kiswa of the Holy KaabaThe occasion was conducted with meticulous organisation. As the previous Kiswa was carefully prepared for removal, the new Kiswa was raised and securely fastened to all sides of the Kaaba. Additionally, the door curtain embroidered with golden embellishments, lantern-shaped pieces, the belt, and samadiyah pieces were affixed-a scene embodying high craftsmanship and precision.The King Abdulaziz Complex for the Holy Kaaba Kiswa is the sole specialist entity responsible for the production of the Kiswa. The production stages are carried out within the complex through a precise production process that begins with the purification of water designated for dyeing, followed by automated weaving, printing, embroidery, and assembly. It concludes with quality assurance measures undertaken by 154 skilled Saudi specialists and technicians.During the production of the Kiswa-which weighs up to 1,415 kilograms-high-quality raw materials are utilised, including 825 kilograms of black-dyed natural silk and 410 kilograms of cotton. The Kiswa is embroidered with 120 kilograms of gold thread and 60 kilograms of silver thread. Additionally, it features 54 gold-coated pieces, comprising the belt, Quranic verses, the door curtain, lantern-shaped pieces, and embellishments surrounding the Mizab and corners.The Kiswa is adorned with 68 Quranic verses from 11 surahs, while the door curtain contains 763 words from the Quran. It is secured using 100 precisely positioned ropes, evenly distributed across all four sides of the Noble Kaaba.The Kiswa stands over 14 metres tall and is made up of five main parts-four of which cover each side of the Kaaba, while the fifth forms the door curtain, embroidered with Quranic verses in gold and silver threads, crafted using precise techniques and profound expertise.The occasion of replacing the Kiswa represents a continuation of the legacy established by the Kingdom of Saudi Arabia since the time of its founder, King Abdulaziz bin Abdulrahman Al Saud-may Allah have mercy upon him. It reaffirms the continuation of this blessed legacy under the direct care of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and his Deputy, His Royal Highness Crown Prince Muhammad bin Salman bin Abdulaziz-may Allah preserve them both. This initiative aligns with the national vision that emphasises excellence in the services provided to the visitors of the Sacred House of Allah.Source: https://alharamain.gov.sa/public/?page=home_enAbout the Authority:An independent body overseeing the Grand Mosque and the Prophet's Mosque.Contact:(+966) 8254241 - (+966) 0148233610Unified Contact Centre: 1966Contact InformationThe General Authority for the Care of the Two Holy MosquesMakkah(+966) 0148233610SOURCE: The General Authority for the Care of The Two Holy Mosques Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Jun 26, 2025 - (ACN Newswire via SeaPRwire.com) - IBI Group Holdings Limited (“IBI” or the “Company”, together with its subsidiaries, the “Group”; Stock Code: 1547), a company focused on investments in the built environment, today announced its audited consolidated results for the year ended 31 March 2025 (“FY2025” or the “year under review”).FY2025 was marked by a challenging global economic environment, which placed significant pressure on the construction industry and resulted in highly competitive tendering conditions. At the same time, global trade tensions triggered unexpected volatility, prompting capital flows to shift towards Asia. This trend has begun to invigorate the Hong Kong market and may help to alleviate some of the pressure on Mainland China's manufacturing sector. Coupled with a strong rebound in inbound tourism and improving market sentiment, these developments have contributed to a more optimistic local outlook. The Group remains confident in Hong Kong’s economic prospects and, with its rigorous risk management, effective cost control, and strategic focus on emerging opportunities, is well positioned to navigate the evolving landscape and drive sustainable growth.During the year under review, the Group demonstrated remarkable resilience and delivered a solid financial performance. Profit attributable to the owners of the Company surged around 23.0 times to approximately HK$8.4 million (FY2024: approximately HK$0.4 million). This increase was mainly attributable to improvement in the Building Solutions segment, the recognition of the unrealised profit generated from financial assets at fair value, and the recognition of a significant fair value loss on investment property in the previous year. Basic and diluted earnings per share was HK1.0 cent (FY2024: HK0.0 cents). The Board has recommended the payment of a final dividend of HK0.5 cents for FY2025 (FY2024: HK0.5 cents).Mr. Neil Howard, Chairman and Chief Executive Officer of IBI, said, “Despite the challenging global economic environment, the Group delivered a strong performance in FY2025, with profitability rising significantly. Furthermore, towards the end of the period, the Group successfully secured four large projects with a total value exceeding the entire turnover for FY2025. This notable result highlights the effectiveness of our strategic focus, the depth of our resilience, and our ability to adapt quickly to change. Looking ahead, we will continue to strengthen our business development, respond swiftly to market dynamics, and pursue continuous improvement to drive long-term value creation and deliver sustainable returns to our shareholders.”Business Review1.ContractingIBI provides world-class interior fitting-out and building refurbishment services in Hong Kong and Macau, predominantly acting as the main contractor for clients across many industry sectors. The construction industry remained under pressure for most of the year. Although the Group completed a higher number of projects compared to the previous period, many were smaller in scale, resulting in a decline in turnover. However, through strict cost control and proactive final accounting by the commercial team, the segment delivered a solid set of results despite the challenging environment. During the year under review, the Group recorded profit from contracting of approximately HK$7.4 million (FY2024: approximately HK$15.2 million), completed 12 projects, and was awarded 13 projects.Notably, during the latter part of the period, the Group secured four large projects with a total value exceeding the entire turnover for FY2025. In May 2025, IBI entered into a memorandum of understanding regarding a potential investment in the development of a new central business district covering around 318 hectares in Manila, the Philippines. Leveraging its expertise in construction and project management, the Group will serve as project advisor, overseeing the project and providing professional advice on construction, procurement, and progress. This collaboration supports the Group’s long-term strategy and, if realised, could diversify its income streams and support long-term growth. These projects will lay a strong foundation for FY2026.In Macau, IBI secured its first project since resuming operations. The Group is actively rebuilding relationships with previous clients and aggressively tendering for new projects.2.Building SolutionsThe Group’s subsidiary, Building Solutions Limited (“BSL”), which provides products and services that enhance the performance and well-being of the built environment in order to provide modern, healthy and high-performing spaces for occupants, recorded a significant and continued improvement in its performance. During the year under review, BSL recorded a segment profit of approximately HK$0.6 million (FY2024: segment loss approximately HK$0.3 million), with sales revenue increasing by 58.2% year on year. BSL achieved profitability during FY2025, marking a significant milestone for the start-up. With continued research and identification of new products, the Group believes that the division’s reputation for delivering high-quality building products and services will achieve further growth.3.Strategic InvestmentsThe Group’s strategic investment division was established to efficiently allocate capital into new market sectors and expand its presence in the built environment. During the year under review, the strategic investments division of the Group recorded a segment profit of approximately HK$0.9 million (FY2024: segment loss approximately HK$3.2 million), which was realised from an unrealised fair value gain on its investment in a large real estate investment trust, a Hong Kong-listed company that owns and manages a diversified and high-quality portfolio. Regarding the assets in Japan, specifically the plots of land in Kutchan, Hokkaido, the Group is continuing to analyse the optimum strategy for the site, and is considering expanding the project, as the analysis indicates that a larger-scale development could provide significant economies of scale and a far greater return on investment. Moving forward, the Group will continue to explore potential investment opportunities and looks forward to announcing further successes in this area.4.Property InvestmentsThe Group’s property investment subsidiary focuses on purchasing physical real estate to generate additional income and expand the Group’s geographical presence. The property investment division of the Group recorded a segment profit of approximately HK$2.5 million for FY2025 (FY2024: segment loss approximately HK$8.1 million), maintaining a steady performance and a 100% occupancy rate. During the year under review, the Group engaged a planning architect to survey the West Wing rooftop area and prepare an initial design for additional commercial space. The Group then held a pre-planning meeting with the local government planning office, which gave positive feedback and indicated that it would not object to the construction of an additional floor. This addition would create 2,500sq ft of tenantable space, which is expected to have a positive impact on the property’s valuation.About IBI Group Holdings Limited (stock code: 1547)IBI Group Holdings Limited is a publicly listed holding company on the Hong Kong Stock Exchange, focused on investments in the Built Environment. The Group’s investments whilst principally centering around the role of contracting, include businesses providing innovative, high quality manufacturing and supply solutions across a diverse range of the built environment. Our mission is to deliver premium products, services and customer experiences with a strong influence of innovation, sustainability and wellness. For more information, please refer to IBI’s website: https://ibighl.com/. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年6月26日 - (亞太商訊 via SeaPRwire.com) - IBI Group Holdings Limited（「IBI」或「公司」及其附屬公司統稱為「集團」；股份代號：1547）為一家專注於建築環境方面投資的公司，今日公佈其截至2025年3月31日止年度（「2025財年」或「回顧年內」）之經審核綜合業績。2025財年，全球經濟環境充滿挑戰，為建造業帶來巨大壓力，投標情況亦變得極為激烈。同時，全球貿易緊張局勢引發市場意想不到的波動，促使資金流向亞洲。這趨勢開始為香港市場注入動力，並有望舒緩中國內地製造業所承受的部分壓力。此外，隨著訪港旅遊強勁反彈及市場氣氛改善，這些發展態勢使本港前景愈發樂觀。集團對香港的經濟前景抱有信心，憑藉嚴謹的風險管理、有效的成本控制及對新機遇的策略性把握，集團將能應對不斷變化的環境，並推動可持續增長。回顧年內，集團展現出非凡韌性，並實現穩健的財務表現。公司擁有人應佔溢利飆升約23.0倍至約8.4百萬港元（2024財年：約0.4百萬港元），增長主要由於Building Solutions分部有所改善、確認按公平值計算的金融資產產生的未變現溢利，以及確認上年度投資物業的重大公平值虧損。每股基本及攤薄盈利為1.0港仙（2024財年：0.0港仙）。董事會建議派發截至2025財年之末期股息每股0.5港仙（2024財年：0.5港仙）。IBI主席兼行政總裁Neil Howard先生表示：「儘管全球經濟環境充滿挑戰，集團於2025財年仍實現強勁表現，盈利能力顯著提升。在回顧年內後期，集團更成功獲得總價值超過2025財年的總營業額的四個大型項目。卓越的表現充分印證我們策略部署的成效、强大的韌性，以及快速應變的能力。展望未來，我們將繼續加強業務發展，靈活應對市場變化，不斷求進，以為股東創造長期價值及可持續的回報。」業務回顧1.承建IBI在香港及澳門提供世界級的室內裝修及樓宇翻新服務，主要為不同行業的客戶擔任總承建商。建築業在回顧年內大部份時間持續受壓，儘管集團完成的項目數量較去年同期有所增加，但其中多個項目規模較小，營業額因而下降。然而，憑藉集團的商務團隊嚴格控制成本及積極進行結算工作，承建分部在充滿挑戰的環境下仍能實現穩健業績。回顧年內，集團錄得來自承建的溢利約7.4百萬港元（2024財年：約15.2百萬港元），完成12個項目，獲授13個新項目。值得留意的是，於回顧年內後期，集團獲得總值超過2025財年整年營業額的四個大型項目。2025年5月，IBI就一項潛在投資訂立諒解備忘錄，以開發一個位於菲律賓馬尼拉市約318公頃的新中央商業區。憑藉在建築及項目管理方面的專業知識，集團將擔任項目顧問，監督項目，並就建設、採購及項目進展提供專業意見。此合作符合集團的長遠策略，倘若項目落實，將拓闊集團的收入來源，並推動其長遠增長。這些項目將為2026財年奠定堅實基礎。在澳門，IBI獲得重新開展業務後的首個項目。集團正與以往的客戶重建關係，並積極參與新項目的投標。2.Building Solutions集團的附屬公司Building Solutions Limited（「BSL」）提供可提升建築環境表現及福祉的產品及服務，以為用者提供現代化、健康及高性能的空間。BSL的業績持續顯著改善，於回顧年內錄得分部溢利約0.6百萬港元（2024財年：分部虧損約0.3百萬港元），銷售收益同比增長58.2%。BSL於2025財年錄得盈利，標誌此初創業務實現重大里程碑，透過持續研究及發掘新產品，集團相信此分部在提供優質建築產品及服務的聲譽將能進一步提升。3.策略投資集團成立策略投資分部旨在將資金有效分配至新的市場領域，並擴大集團於建築環境領域的影響力。回顧年內，集團的策略投資分部錄得分部溢利約為0.9百萬港元（2024財年：分部虧損約3.2百萬港元）。該分部溢利是由於集團於大型房地產投資信託基金的投資出現未實現公平值收益而實現，該香港上市公司擁有及管理多元化及優質的投資組合。就集團的日本資產而言，即位於北海道俱知安町的地塊，集團正持續對該地塊進行分析並制定最佳戰略。分析顯示更大規模的開發可帶來顯著的經濟效益及更高的投資回報，因此集團正考慮擴大此項目。展望未來，集團將繼續發掘潛在的投資機會，並期待於該領域公佈更多佳績。4.投資物業集團的物業投資附屬公司專注於收購實體房地產，以為集團帶來額外收入，並擴大其地域覆蓋範圍。集團的物業投資部於2025財年錄得分部溢利約為2.5百萬港元（2024財年：分部虧損約8.1百萬港元），保持穩健業績並維持百分之百的出租率。回顧年內，集團委聘規劃建築師對西翼屋頂區域進行勘測，並為額外的商業空間進行初步設計。隨後，集團與當地政府規劃辦公室舉行了規劃前會議。規劃辦公室給予了積極反饋，並表示不反對增建一層。此次增建將創造2,500平方英呎的可租用空間，預期將對該物業的估值產生正面影響。關於IBI Group Holdings Limited（股份代號︰1547）IBI Group Holdings Limited 為香港主板上市控股公司，專注於建築環境方面的投資。集團的投資以承建為核心，同時涵蓋多個業務範疇，提供建築環境多個領域的創新、優質製造及供應解決方案。集團的使命是通過創新、可持續發展及健康的理念，提供卓越的產品、服務和客戶體驗。有關IBI的詳情，請瀏覽網站：https://ibighl.com/. Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年6月26日 - (亞太商訊 via SeaPRwire.com) - 2025年6月25日，中國領先的科技出行平台曹操出行（股份代號：02643.HK）於港交所主板上市，成為港股最大的出行平台。曹操出行董事會主席楊健在上市致辭中表示：「展望未來，共享出行面臨顛覆性的行業變革，原有的競爭格局將被重塑。借助吉利集團資源優勢，曹操出行將深度參與網約車定制研發，優化車輛性能和服務功能，全力推進自動駕駛網約車的研發和上市；在換電補能、循環再製造，醇氫能源網約車運營、AI管理等方面構建更加完善的出行生態，為乘客提供更安全、高效、便捷的出行選擇。」上市儀式現場，曹操出行執行董事兼CEO龔昕與曹操出行執行總裁兼CFO柳森森共同敲響金鑼，曹操出行股票正式上市交易。掛牌上市是曹操出行發展的重要里程碑，彰顯了市場對其商業模式、增長潛力及行業領先地位的認可，也為投資者提供了參與中國智慧出行產業高速發展的優質通道。規模高速增長，服務品質領先招股書顯示，截至2025年3月末，曹操出行覆蓋城市增至146座，一季度總GTV同比增長54.9%，訂單量同比增長51.8%，取得收入42億元，毛利率升至8.5%，各項核心指標較2024年同期均實現大幅提升。憑藉規模化提供優質服務，曹操出行建立了顯著的品牌優勢。在2023年至2024年間的五次獨立第三方調查中，曹操出行獲評為行業「服務口碑最佳」。弗若斯特沙利文資料顯示，曹操出行服務訂單事故率顯著低於行業均值。同時曹操出行積極履行社會責任，無障礙專車服務已經在曹操出行APP等20餘個平台上線，並同步在杭州、蘇州等城市開展「無障礙公益日」活動，提供免費無障礙出行服務。定制車優化TCO，提升單位經濟效益截至2024年12月31日，曹操出行在31座城市運營超過3.4萬輛定制車，為中國同類最大定制車隊，定制車型訂單GTV占比從2023年的20.1%提升至2024年的25.1%。曹操出行持續部署定制車並升級車服解決方案。楓葉80V及曹操60兩款定制車聚焦出行場景，提升了耐用性與可維修性，採用換電架構及智能座艙。車服方案方面，吉利生態夥伴易易互聯在全國26城的378座換電站支持定制車60秒換電；133家吉利授權維修點使車輛平均保養、維修的時間和成本分別下降25%和54%。據弗若斯特沙利文資料，曹操出行定制車的平均TCO（總持有成本）較典型純電動汽車降低36.4%。依託與吉利集團的深度合作，曹操出行實現車輛從設計、部署、定價、銷售到運營服務的全生命週期管理。通過優化乘客體驗、降低車輛全週期成本（TCO）及提升司機能源補給效率等舉措，構建了差異化競爭優勢。構建Robotaxi閉環生態，卡位萬億未來出行2025年2月28日，曹操智行自動駕駛平台上線，搭載吉利「千里浩瀚」Robotaxi解決方案的車輛在蘇州、杭州啟動示範運營。背靠吉利集團，曹操出行構建了國內首個「定制車+自動駕駛技術+出行平台」全域自研閉環生態，成為國內唯一具備類似特斯拉「製造+智駕+運營」全鏈條能力的出行公司。Robotaxi服務無縫整合了曹操的運營經驗與吉利集團的汽車製造、自動駕駛技術優勢，曹操出行基於定制車已驗證的服務標準化能力、成本優化路徑和成熟的資產管理體系，將有力推動Robotaxi服務的商業化落地。曹操出行計畫2026年底推出專為自動駕駛設計的L4級Robotaxi定制車型，將預裝自動駕駛元件及應用程式，適合長時間運行並具備相對較低的TCO，以及便捷乘客的設計和配置。同時，公司將構建覆蓋車輛保養維修、能源補充、客服、應急回應及訂單優化等全場景的自動化運營系統，進一步提升大規模運營Robotaxi的能力。 Copyright 2025 亞太商訊 via SeaPRwire.com.

Parties negotiating terms of definitive agreementAgreement intended to launch New Rise Australia as a SAF and HVO platform driven by XCF's patent-pending site design and configurationAgreement expected to include equity stake, license fees, and exclusive rights to the Australian marketIntended partnership in line with announced strategy regarding international expansionHOUSTON, TX and SOUTH PERTH, WESTERN AUSTRALIA, June 26, 2025 - (ACN Newswire via SeaPRwire.com) - XCF Global, Inc. ("XCF") (NASDAQ:SAFX), a key player in decarbonizing the aviation industry through Synthetic Aviation Fuel ("SAF"), and Continual Renewable Ventures Pty. Ltd. ("Continual"), an Australian-based company with a focus on advancing SAF and hydrotreated vegetable oil ("HVO"), also known as renewable diesel, today announced the signing of a non-binding Memorandum of Understanding ("MOU") that seeks to launch New Rise Australia Pty. Ltd. ("New Rise AU"), a venture dedicated to the development and commercialization of synthetic aviation fuel projects across Australia.New Rise AU is expected to operate under a licensing agreement that leverages XCF's integrated SAF platform - including patent-pending site design, configuration, and layout that shortens development timelines and improves capital efficiency. Designed for rapid deployment and scalable growth, the first Australian facility is expected to follow the blueprint of XCF's New Rise Reno facility."This partnership underscores the strength of XCF's platform and validates our unique, capital-efficient approach to facility development. Our patent-pending site design and modular configuration give ventures like New Rise AU a strategic head start in high-demand markets," said Mihir Dange, Chief Executive Officer and Board Chair of XCF Global. "The Australian market is primed for SAF growth, with strong regulatory support, rising demand from the aviation sector, and a focus on cutting emissions. We're excited to bring our blueprint to the region and proud to work alongside a team that shares our ambition to accelerate the clean energy transition."Renzo Petersen, Director of Continual, added: "We chose XCF because of their innovative approach to SAF and HVO facility design, which enables faster, more efficient deployment at scale. This partnership gives us a head start in building Australia's next-generation SAF and HVO infrastructure. We're proud to collaborate with XCF to bring SAF and HVO solutions to Australia. Together, we're laying the foundation for a scalable, commercially viable platform that supports Australia's decarbonization goals and positions New Rise AU as a regional leader in sustainable fuel."Today's announcement marks a key milestone in XCF's international expansion strategy and builds on the company's momentum following the recent commissioning of its New Rise Reno facility in Reno, Nevada and listing on the Nasdaq Capital Market.Definitive agreements are expected to be completed in the coming months, with legal, technical, and commercial diligence already underway. However, there can be no assurance that the parties will enter into definitive agreements in a timely manner or at all, or, if definitive agreements are reached, that the terms will be consistent with the terms outlined in the MOU.About XCF Global, Inc.XCF Global, Inc. is a pioneering synthetic aviation fuel company dedicated to accelerating the aviation industry's transition to net-zero emissions. XCF is developing and operating state-of-the-art clean fuel SAF production facilities engineered to the highest levels of compliance, reliability, and quality. The company is actively building partnerships across the energy and transportation sectors to accelerate the adoption of SAF on a global scale. XCF is currently listed on the Nasdaq Capital Market and trades under the ticker, SAFX. To learn more, visit www.xcf.global.About Continual Renewable Ventures Pty. Ltd.Continual Renewable Ventures Pty. Ltd. is an Australian-based company committed to building the infrastructure required to support the long-term decarbonization of the transportation industry in Australia. With a focus on advancing SAF and HVO projects, the company brings together an experienced team of seasoned entrepreneurs, engineers, and Indigenous business leaders who are united by a shared commitment to innovation, sustainability, and economic development.Forward-Looking StatementsThis Press Release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expect", "intend", "will", "estimate", "anticipate", "believe", "predict", "potential" or "continue", or the negatives of these terms or variations of them or similar terminology. These forward-looking statements, including, without limitation, statements regarding XCF Global's expectations with respect to future performance and anticipated financial impacts of the Business Combination, estimates and forecasts of other financial and performance metrics, and projections of market opportunity and market share, are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by XCF Global and its management, are inherently uncertain and subject to material change. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political, and legal conditions; (2) unexpected increases in XCF Global's expenses resulting from potential inflationary pressures and rising interest rates, including manufacturing and operating expenses and interest expenses; (3) the occurrence of any event, change or other circumstances that could give rise to the termination of negotiations and any agreements with regard to XCF Global's offtake arrangements; (4) the outcome of any legal proceedings that may be instituted against the parties to the Business Combination Agreement or others; (5) XCF Global's ability to meet Nasdaq's continued listing standards; (6) XCF Global's ability to integrate the operations of New Rise and implement its business plan on its anticipated timeline; (7) XCF Global's ability to raise financing in the future and the terms of any such financing; (8) New Rise's ability to produce the anticipated quantities of SAF without interruption or material changes to the SAF production process; (9) XCF Global's ability to resolve current disputes between New Rise and its landlord with respect to the ground lease for the New Rise Reno facility; (10) XCF Global's ability to resolve current disputes between New Rise and its primary lender with respect to loans outstanding that were used in the development of the New Rise Reno facility; (11) costs related to the Business Combination and the New Rise acquisitions; (12) the risk of disruption to the current plans and operations of XCF Global as a result of the consummation of the Business Combination; (13) XCF Global's ability to recognize the anticipated benefits of the Business Combination and the New Rise acquisitions, which may be affected by, among other things, competition, the ability of XCF Global to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (14) changes in applicable laws or regulations; (15) risks related to extensive regulation, compliance obligations and rigorous enforcement by federal, state, and non-U.S. governmental authorities; (16) the possibility that XCF Global may be adversely affected by other economic, business, and/or competitive factors; (17) the availability of tax credits and other federal, state or local government support; (18) risks relating to XCF Global's and New Rise's key intellectual property rights; (19) the risk that XCF Global's reporting and compliance obligations as a publicly-traded company divert management resources from business operations; (20) the effects of increased costs associated with operating as a public company; and (21) various factors beyond management's control, including general economic conditions and other risks, uncertainties and factors set forth in XCF Global's filings with the Securities and Exchange Commission ("SEC"), including the final proxy statement/prospectus relating to the Business Combination filed with the SEC on February 6, 2025, this Press Release and other filings XCF Global makes with the SEC in the future. If any of the risks actually occur, either alone or in combination with other events or circumstances, or XCF Global's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that XCF Global does not presently know or that it currently believes are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect XCF Global's expectations, plans or forecasts of future events and views as of the date of this Press Release. These forward-looking statements should not be relied upon as representing XCF Global's assessments as of any date subsequent to the date of this Press Release. Accordingly, undue reliance should not be placed upon the forward-looking statements. While XCF Global may elect to update these forward-looking statements at some point in the future, XCF Global specifically disclaims any obligation to do so.ContactsXCF Global, Inc.:Chris Santa Cruzinvest@xcf.globalFor Media:Fatema Bhabrawalafbhabrawala@allianceadvisors.comSOURCE: XCF Global, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.

深圳，2025年6月25日 - (亞太商訊 via SeaPRwire.com) - 康哲藥業控股有限公司（以下簡稱「康哲藥業」）之董事會宣佈，建議將其普通股（「股份」）以介紹方式於新加坡證券交易所有限公司（「新交所」）作第二上市（「建議第二上市」）。建議第二上市（倘落實進行）將不涉及增發新股，其後股份將繼續於香港聯合交易所有限公司作主要上市及買賣。康哲藥業已按保密基準向新交所遞交建議第二上市之上市申請。截至本公告日期，康哲藥業尚未自新交所接獲建議第二上市之上市資格函（「上市資格函」）。於2025年6月24日，康哲藥業接獲中國證券監督管理委員會（「中國證監會」）就建議第二上市發出之境外發行上市備案通知書。董事相信，完成新交所建議第二上市後，可吸引專注亞太投資的基金及東南亞本土資本，優化股東結構。同時，也將對康哲藥業在東南亞及中東的業務發展帶來更爲深遠的影響。康哲藥業以新加坡爲東南亞及中東業務總部，並已在當地設立藥品研、產、銷、投全鏈條業務發展公司，包括CMS R&D爲自主研發國際化發展公司，PharmaGend爲藥品製造CMO/CDMO公司，Rxilient爲藥品開發、註冊與商業化公司，新加坡創投爲產業投資公司，協力爲東南亞患者提供更多優質、可負擔的用藥選擇，爲東南亞醫藥產業鏈發展貢獻力量，提升康哲藥業全球知名度與市場地位，從而助力康哲藥業全球本土化戰略落地，爲其帶來額外的增長貢獻。康哲藥業將於必要時根據適用法律及法規就建議第二上市作出進一步公告。建議第二上市須待新交所授出上市資格函及達成上市資格函所載之任何條件後方可作實。因此，概不保證建議第二上市將會落實完成。康哲藥業股東及潛在投資者於買賣公司證券時務請審慎行事。關於康哲藥業康哲藥業是一家鏈接醫藥創新與商業化，把控產品全生命週期管理的開放式平臺型企業，致力於提供有競爭力的產品和服務，滿足尚未滿足的醫療需求。康哲藥業專注於全球首創（FIC）及同類最優（BIC）的創新產品，並高效推進創新產品臨牀研究開發和商業化進程，賦能科研成果向診療實踐的持續轉化，造福患者。康哲藥業聚焦專科領域，擁有被驗證的商業化能力，廣泛的渠道覆蓋和多疾病領域專家資源，核心在售產品已獲領先的學術與市場地位。康哲藥業圍繞優勢專科領域不斷縱深發展，以鞏固心腦血管/消化業務競爭力，並將皮膚健康、眼科業務獨立運營，培育專科小領域的大龍頭，提升專科規模效率。同時業務版圖拓展至東南亞市場，着力成爲全球藥企進軍東南亞市場的「橋頭堡」，助力康哲藥業高質量持續健康發展。康哲藥業免責與前瞻性聲明本新聞無意向您做任何產品的推廣，非廣告用途。本新聞不對任何藥品和醫療器械和/或適應症作推薦。若您想了解具體疾病診療信息，請遵從醫生或其他醫療衛生專業人士的意見或指導。醫療衛生專業人士作出的任何與治療有關的決定應根據患者的具體情況並遵照藥品說明書。由康哲藥業編制的此新聞不構成購買或認購任何證券的任何要約或邀請，不形成任何合約或任何其他約束性承諾的依據或加以依賴。本新聞由康哲藥業根據其認爲可靠之資料及數據編制，但康哲藥業並無進行任何說明或保證、明述或暗示，或其他表述，對本新聞內容的真實性、準確性、完整性、公平性及合理性不應加以依賴。本新聞中討論的若干事宜可能包含涉及康哲藥業的市場機會及業務前景的陳述，該等陳述分別或統稱爲前瞻性聲明。該等前瞻性聲明並非對未來表現的保證，存在已知及未知的風險、不明朗性及難以預知的假設。康哲藥業並不採納本新聞包含的第三方所做的任何前瞻性聲明及預測，康哲藥業對該等第三方聲明及預測不承擔責任。 Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, Jun 25, 2025 - (ACN Newswire via SeaPRwire.com) - Galaxy Payroll Group Limited (NASDAQ: GLXG, “Galaxy Group”), a leading global payroll provider, announced today the signing of a Memorandum of Understanding (MOU) to jointly develop innovative AI-powered HR solutions. The partnership will combine Galaxy's payroll expertise with CURRENC's artificial intelligence technology to create advanced tools for modern workforce management.The cooperation, as outlined in the MOU, will focus on the development of two key modules that leverage the combined strengths of both parties. The “AI HR & Payroll Manager” will integrate Galaxy's extensive payroll expertise with CURRENC's advanced AI capabilities to streamline and enhance HR and payroll operations. This module will also introduce cryptocurrencies, particularly stablecoins, as a payment option for payroll processing, aligning with the growing trend of digital payments and offering clients a more efficient and secure payment alternative.The “AI Recruitment Manager” will utilize data-driven automation technology to optimize the recruitment process, providing intelligent candidate screening and automated interview scheduling. This system aims to help enterprises accurately match talents with job requirements, significantly improving the efficiency and effectiveness of their recruitment processes. Together, these modules will not only enhance operational efficiency but also provide clients with innovative solutions that address modern workforce challenges.Speaking of the strategic significance of this cooperation, Wai Hong Lao, Chairman and Chief Executive Officer of Galaxy Payroll Group, said, “Integrating stablecoins into our AI-driven HR product suite represents a dual innovation. It not only keeps pace with the current trend of digital payments but also enhances operational efficiency for our multinational clients, helping them achieve HR management upgrade in the digital era.”Alex Kong, Founder and Executive Chairman of CURRENC, stating, “By combining Galaxy’s professional payroll service advantages with our accumulated AI technology in the financial field, we are confident in creating next-generation HR tools that can meet the challenges of today’s labor market and provide enterprises with more competitive solutions.”About CURRENC Group Inc.CURRENC Group Inc. (Nasdaq: CURR) is a fintech pioneer dedicated to transforming global financial services through artificial intelligence (AI). The Company empowers financial institutions worldwide with comprehensive AI solutions, including SEAMLESS AI Call Centre and other AI-powered Agents designed to reduce costs, increase efficiency and boost customer satisfaction for banks, insurance, telecommunications companies, government agencies, cryptocurrency exchanges and other financial institutions. The Company’s digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 global payment services, advancing financial access across underserved communities.About Galaxy Payroll Group LimitedGalaxy Payroll Group Limited is a leading payroll outsourcing service provider based in Hong Kong. The company specializes in delivering HR and payroll solutions to multinational companies across various industries. With a focus on innovation and client satisfaction, GLXG operates in Hong Kong, Taiwan, Macau, and the PRC, offering payroll outsourcing, employment services, and consultancy to businesses of all sizes.For more information, please visit Galaxy Payroll Group's website: www.galaxyapac.com.Forward-Looking StatementsMatters discussed in this press release may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The words "believe," "anticipate," "intends," "estimate," "potential," "may," "should," "expect" "pending" and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations.For enquiry, please contact Intelligent Joy Limited:Karen DengPhone: (852) 3594 6407Email: pr-team@intelligentjoy.com Copyright 2025 ACN Newswire via SeaPRwire.com.

SHENZHEN, June 25, 2025 - (ACN Newswire via SeaPRwire.com) - The board of directors of China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group”) announces the proposed secondary listing of the Company’s ordinary shares (“Shares”) on the Singapore Exchange Securities Trading Limited (the “SGX-ST”) by way of introduction (the “Proposed Secondary Listing”). The Proposed Secondary Listing, if proceeded, will not involve issuance of new shares, and the Shares will continue to be primarily listed and traded on the Hong Kong Stock Exchange thereafter.The Company has submitted, on a confidential basis, an application to the SGX-ST in relation to the Proposed Secondary Listing. As of the date of this announcement, the Company has not received the eligibility-to-list letter (“ETL”) from the SGX-ST in respect of the Proposed Secondary Listing.On June 24, 2025, the Company received the Notice of Overseas Issuance and Listing Filing from the China Securities Regulatory Commission (the “CSRC”) in respect of the Proposed Secondary Listing.The Directors believe that upon completion of the proposed secondary listing on the SGX-ST, the Group will be able to attract funds focusing on Asia-Pacific investments and local capital in Southeast Asia, thereby optimizing the shareholder structure. At the same time, it will also have a more profound impact on the Group’s business development in Southeast Asia and the Middle East. The Group has established Singapore as its regional headquarters for its Southeast Asia and Middle East business, and has set up companies in Singapore covering the entire pharmaceutical value chain of R&D, manufacturing, commercialization and investment, including CMS R&D as the international independent R&D company, PharmaGend as the pharmaceutical manufacturing CMO/CDMO company, Rxilient as the pharmaceutical development, registration and commercialization company, and Singapore Venture Capital as the industrial investment company. These companies work together to provide Southeast Asian patients with more high-quality and affordable treatment options, contribute to the development of the pharmaceutical industry chain in Southeast Asia, enhance the Group’s global reputation and market position, promote the implementation of the Group’s “Glocalization” strategy, and bring additional growth to the Group.The Company will make further announcements with respect to the Proposed Secondary Listing as and when necessary in compliance with the applicable laws and regulations.The Proposed Secondary Listing is subject to the SGX-ST granting an ETL and the fulfilment of any conditions set out in the ETL. As such, there is no assurance that the Proposed Secondary Listing will proceed to completion. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the securities of the Company.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its skin health and ophthalmology businesses, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a "bridgehead" for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com.

Perth, Australia--(ACN Newswire via SeaPRwire.com - June 25, 2025) - The Investing News Network (INN), a global leader in independent news and investor education focused on publicly listed companies, is pleased to announce the appointment of John Phillips as Country Head, Australia. This strategic hire underscores INN's ongoing commitment to supporting Australian-listed companies and connecting them with a growing base of active, informed investors.Phillips brings more than two decades of media, financial publishing and investor engagement experience. His deep industry knowledge and trusted reputation in Australia's capital markets will be instrumental as INN expands its reach and services across the region."Australia remains one of the world's most dynamic markets for early-stage and resource-focused public companies. We're committed to providing these issuers with the tools and exposure they need to reach global investors," said Chris Hogg, Chief Revenue Officer of INN. "Bringing John on board represents a major step forward in that mission. His expertise and relationships across the sector will allow us to deliver even greater value to our clients and our audience."INN has operated in Australia since 2017 and continues to grow its audience of retail investors interested in commodities, technology, life sciences and more. The network produces original news, interviews and investor reports that help demystify complex sectors and improve access to credible company insights."This is a unique opportunity to help grow a trusted brand with a global footprint and bring greater visibility to the incredible innovation happening across the ASX," said Phillips. "I'm excited to join INN and help strengthen its position as a key bridge between companies and investors."For more information on INN's services or its expansion in Australia, please visit www.investingnews.com or contact:John Phillips+61 431 597 771jphillips@investingnews.comAbout Investing News NetworkThe Investing News Network (INN) is a destination for trusted, independent news and education for investors exploring the public markets. With sector-specific coverage and direct access to company insights, INN helps investors make informed decisions - and helps public companies improve visibility and attract shareholder interest.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/256806 Copyright 2025 ACN Newswire via SeaPRwire.com.